With the project the investigators propose, the investigators aim to find answers to the following questions: Are some cachectic factors and cytokines associated with plasma level irisin in patients with advanced stage cancer diagnosed with CACS? Could irisin be a new cachectic factor for patients with CACS? Can providing nutritional education to these patients slow cachexia and can a quality survival be achieved in line with the data obtained from the assessment of quality of life? and the experimental approaches to find answers to these questions make this project unique.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
SF-36 Quality of Life Scale
Timeframe: 12 weeks
Determination of biochemical parameters by ELISA method
Timeframe: 12 weeks
Hemoglobin measurument in plasma samples
Timeframe: 12 weeks
Body Mass Index Measurument
Timeframe: 12 weeks
C-reactive protein measurument in plasma samples
Timeframe: 12 weeks
Alanine transaminase measurument in plasma samples
Timeframe: 12 weeks
Aspartate transaminase measurument in plasma samples
Timeframe: 12 weeks
Urea measurument in plasma samples
Timeframe: 12 weeks
Creatinine measurument in plasma samples
Timeframe: 12 WEEKS
Prealbumin measurument in plasma samples
Timeframe: 12 weeks
Transferrin measurument in plasma samples
Timeframe: 12 weeks
albumin measurument in plasma samples
Timeframe: 12 weeks
fibrinogen measurument in plasma samples
Timeframe: 12 WEEKS
Ceruloplasmin measurement in plasma samples
Timeframe: 12 weeks
Alpha-1 antitrypsin measurement in plasma samples
Timeframe: 12 weeks
Cancer antigen 15-3 measurement in plasma samples
Timeframe: 12 weeks
Cancer antigen 19-9 measurement in plasma samples
Timeframe: 12 weeks
carcinoembryonic antigen (CEA) measurement in plasma samples
Timeframe: 12 weeks